Teladoc Health, Inc. TDOC
9.58 USD +0.69 (+7.76%)
Nov 4, 2026, 12:32 PM EST
8.83 Day range 9.58
4.40 52-week range 9.89
- YTD
- +36.86%
- 1 year
- +20.05%
Analyst view
Consensus: hold
Hold
Price target (mean) 8.47 -11.6% downside
Now 9.58
- Target (low)
- 6.00
- Target (mean)
- 8.47
- Target (high)
- 11.50
Ratings (0m) 23 6 buy · 16 hold · 1 sell
- Strong buy1
- Buy5
- Hold16
- Sell1
- Strong sell0
Recommendation trend
- This month 23
- 1 month ago 23
- 2 months ago 23
- 3 months ago 24
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.13 | -0.19 – -0.07 | -0.1034 | -25.7% | 595.20M | -7.3% | 2 |
| Next quarter | -0.19 | -0.24 – -0.14 | -0.2836 | +33.0% | 584.95M | -4.7% | 2 |
| Current year | -0.68 | -1.03 – -0.39 | -0.6563 | -3.6% | 2.42B | -4.4% | 4 |
| Next year | -0.63 | -1.03 – -0.26 | -0.68 | +7.3% | 2.35B | -2.8% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | UBS | Maintained | Neutral | Neutral |
| Nov 2, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 30, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Stifel | Maintained | Hold | Hold |
| Oct 29, 2026 | Needham | Reiterated | Hold | Hold |
| Aug 3, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 30, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Jul 21, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 7, 2026 | B of A Securities | Maintained | Buy | Buy |
| May 5, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Apr 8, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Mar 26, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Mar 13, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Mar 10, 2026 | Deutsche Bank | Upgrade | Hold | Buy |
| Mar 3, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Mar 3, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 26, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 26, 2026 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Feb 26, 2026 | TD Cowen | Maintained | Hold | Hold |
| Feb 26, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Feb 26, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Feb 26, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Feb 26, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Feb 26, 2026 | Stifel | Maintained | Hold | Hold |
| Jan 9, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Dec 9, 2025 | Barclays | Initiated | — | Equal-Weight |
| Nov 25, 2025 | B of A Securities | Maintained | Neutral | Neutral |
| Nov 13, 2025 | BMO Capital | Initiated | — | Market Perform |
| Oct 30, 2025 | Evercore ISI Group | Maintained | In-Line | In-Line |